
(3S)-5-Fluoro-3-methyl-1(3H)-isobenzofuranone serves as an essential chiral synthetic building block and critical regulatory intermediate in oncology medicinal chemistry, primarily utilized in the synthesis of Lorlatinib, a highly potent third-generation anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1) receptor tyrosine kinase inhibitor. Its rigid fluorinated chiral phthalide core efficiently establishes the stereospecific pharmacophore necessary to combat resistance mutations (such as G1202R) encountered in non-small cell lung cancer (NSCLC) treatments and to improve central nervous system penetration against brain metastases. The substance is widely applied in pharmaceutical scale-up route optimization, commercial active pharmaceutical ingredient (API) manufacturing, impurity reference profiling, and medicinal discovery programs targeting novel tyrosine kinase inhibitors.
If you would like to make an inquiry or learn more about the products, please fill in the following form, we will reply in 24 hours.